Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses

BACKGROUND: Co-infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) is not infrequent as both share same route of exposure. The risk of developing chronic hepatitis B virus is 6%, in general population but can reach 10–20% in HBV/HIV co-infected patients. When compared to ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornejo-Juárez, Patricia, Volkow-Fernández, Patricia, Escobedo-López, Kenia, Vilar-Compte, Diana, Ruiz-Palacios, Guillermo, Soto-Ramírez, Luis Enrique
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1468419/
https://www.ncbi.nlm.nih.gov/pubmed/16600028
http://dx.doi.org/10.1186/1742-6405-3-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1468419/
https://www.ncbi.nlm.nih.gov/pubmed/16600028
http://dx.doi.org/10.1186/1742-6405-3-9

Ejemplares similares